Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Benjamin D Greenbaum
Affiliation
Memorial Sloan Kettering Cancer Center
ORCID
Career Start Year
2003
Papers
88
H Index
36
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36927002
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.
J Clin Oncol
2023
37609261
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity.
bioRxiv
2023
37872381
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia.
Nat Cancer
2023
37494469
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse.
Sci Transl Med
2023
37292765
Cancer cells co-evolve with retrotransposons to mitigate viral mimicry.
bioRxiv
2023
37024582
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
Nat Genet
2023
37159385
High-throughput interrogation of immune responses using the Human Immune Profiling Pipeline.
STAR Protoc
2023
37474509
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector.
Nat Commun
2023
37165196
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature
2023
37327118
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.
Blood Adv
2023
34644393
Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York City.
Clin Infect Dis
2022
35679859
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 TÂ cell responses.
Cancer Cell
2022
35383292
The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein.
Cell Death Differ
2022
35708912
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.
J Clin Invest
2022
35545680
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
2022
35767426
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.
Clin Cancer Res
2022
35704596
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Sci Transl Med
2022
35641605
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
2022
35789859
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.
iScience
2022
35589842
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.
Nature
2022
35972475
Perfecting antigen prediction.
J Exp Med
2022
35320348
Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
Cancer Discov
2022
34937774
sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
RNA
2022
33184911
Frontiers in cancer immunotherapy-a symposium report.
Ann N Y Acad Sci
2021
33555346
The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
Mol Biol Evol
2021
35122060
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial.
Nat Cancer
2021
34473697
Probing T-cell response by sequence-based probabilistic modeling.
PLoS Comput Biol
2021
34630437
Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
Front Immunol
2021
34075878
HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.
Elife
2021
34171309
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Cell
2021
32511407
The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2.
bioRxiv
2020
31836853
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.
Leukemia
2020
31857430
Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.
Clin Cancer Res
2020
32096295
Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus.
Pigment Cell Melanoma Res
2020
33298930
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.
Nat Commun
2020
33259803
Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors.
Cell
2020
32976222
An integrative approach identifies dysregulated long non-coding RNAs as microRNA decoys during nevus to melanoma transformation.
Melanoma Res
2020
32714120
The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
SSRN
2020
32766600
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection.
medRxiv
2020
32505227
Immunology of COVID-19: Current State of the Science.
Immunity
2020
32117226
Computational Prediction and Validation of Tumor-Associated Neoantigens.
Front Immunol
2020
32561401
COVID-19 in patients with lung cancer.
Ann Oncol
2020
30626867
A tumor-specific endogenous repetitive element is induced by herpesviruses.
Nat Commun
2019
31409730
Correction for Sobel Leonard et al., "Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus".
J Virol
2019
31406345
Reply to 'Reconciling disparate estimates of viral genetic diversity during human influenza infections'.
Nat Genet
2019
29217585
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.
Science
2018
30177761
Influenza virus infection causes global RNAPII termination defects.
Nat Struct Mol Biol
2018
29950349
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial.
Clin Cancer Res
2018
29642008
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.
Cell Rep
2018
29665239
FBXW7 regulates a mitochondrial transcription program by modulating MITF.
Pigment Cell Melanoma Res
2018
1 - 50 of 88
Column Actions
Search
Recommended Authors
Chase W Nelson
Biodiversity Research Center, Taiwan Institute for Comparative Genomics
Career Start Year
2011
Number of shared co-authors
3
Dan J Woodcock
University of Oxford
Career Start Year
2010
Number of shared co-authors
0
Thiago Y Oliveira
The Rockefeller University
Career Start Year
2010
Number of shared co-authors
0
Joseph B Hiatt
Fred Hutchinson Cancer Center
Career Start Year
2009
Number of shared co-authors
9
Alvin Farrel
Children's Hospital of Philadelphia
Career Start Year
2008
Number of shared co-authors
0
Kristen K Dang
Benaroya Research Institute at Virginia Mason
Career Start Year
2006
Number of shared co-authors
3
Fabio Zanini
Stanford University
Career Start Year
2006
Number of shared co-authors
1
Fergal Casey
Biogen Inc.
Career Start Year
2006
Number of shared co-authors
3
Maria Chikina
University of Pittsburgh
Career Start Year
2005
Number of shared co-authors
7
Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2005
Number of shared co-authors
1
Ville Mustonen
University of Helsinki
Career Start Year
2004
Number of shared co-authors
1
Christopher E Mason
Feil Family Brain and Mind Research Institute.
Career Start Year
2004
Number of shared co-authors
10
Vladimir Jojic
Calico Life Sciences LLC
Career Start Year
2003
Number of shared co-authors
3
Niko Beerenwinkel
ETH Zurich
Career Start Year
2002
Number of shared co-authors
1
Nels C Elde
University of Utah School of Medicine
Career Start Year
2001
Number of shared co-authors
5
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year
2001
Number of shared co-authors
4
Jason F Kreisberg
University of California San Diego
Career Start Year
2000
Number of shared co-authors
3
Michael C Wendl
Washington University in St Louis
Career Start Year
1998
Number of shared co-authors
6
Lindsay G Cowell
University of Texas Southwestern Medical Center
Career Start Year
1998
Number of shared co-authors
0
Pardis C Sabeti
Harvard University
Career Start Year
1997
Number of shared co-authors
5
Robert A Holt
BC Cancer Research Institute
Career Start Year
1996
Number of shared co-authors
9
Sarah A Teichmann
Wellcome Sanger Institute
Career Start Year
1996
Number of shared co-authors
8
Adam S Lauring
University of Michigan ann arbor
Career Start Year
1995
Number of shared co-authors
5
Joseph L DeRisi
University of California San Francisco
Career Start Year
1994
Number of shared co-authors
4
Fran Supek
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year
1992
Number of shared co-authors
0
Vesteinn Thorsson
Institute for Systems Biology
Career Start Year
1990
Number of shared co-authors
4
Gustavo Stolovitzky
IBM T.J. Watson Research Center
Career Start Year
1990
Number of shared co-authors
9
Aviv Bergman
Albert Einstein College of Medicine
Career Start Year
1990
Number of shared co-authors
1
Nir Yosef
Center for Computational Biology, University of California berkeley
Career Start Year
1986
Number of shared co-authors
6
Richard H Scheuermann
J. Craig Venter Institute
Career Start Year
1983
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Arnold J Levine
Simons Center for Systems Biology, Institute for Advanced Study
Co-authored papers
13
Elodie Ghedin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
7
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers
5
Ivan Marazzi
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers
4
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Co-authored papers
4
Chaitanya Bandlamudi
Co-authored papers
4
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Timothy A Chan
Cleveland Clinic.
Co-authored papers
4
Andrew Chow
Co-authored papers
4
Nir Hacohen
Broad Institute of MIT and Harvard
Co-authored papers
4
Edward C Holmes
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers
3
Mithat Gonen
Co-authored papers
3
Romain Remark
Co-authored papers
3
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Hira Rizvi
Druckenmiler Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Diana Low
Institute of Molecular and Cell Biology (IMCB)
Co-authored papers
3
Jayon Lihm
Co-authored papers
3
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Shashank Tripathi
Indian Institute of Science
Co-authored papers
2
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers
2
Nan Zhao
Department of Computer Science and Informatics Institute, University of Missouri
Co-authored papers
2
El-Ad David Amir
Co-authored papers
2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
2
Natasha Moshkina
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
1 - 30